Bensensulfonamider
Filtrerade sökresultat
Benzenesulfonamide, 98+%
CAS: 98-10-2 Molekylformel: C6H7NO2S Molekylvikt (g/mol): 157.19 MDL-nummer: MFCD00007930 InChI-nyckel: KHBQMWCZKVMBLN-UHFFFAOYSA-N Synonym: benzenesulphonamide,benzosulfonamide,benzolsulfonamide,phenyl sulfonamide,benzene sulfonamide,phenylsulfonamide,m and b 7973,chembl27601,benzolsulfonamid,benzensulfonamide PubChem CID: 7370 IUPAC-namn: bensensulfonamid LEDER: C1=CC=C(C=C1)S(=O)(=O)N
| Molekylformel | C6H7NO2S |
|---|---|
| PubChem CID | 7370 |
| MDL-nummer | MFCD00007930 |
| IUPAC-namn | bensensulfonamid |
| CAS | 98-10-2 |
| InChI-nyckel | KHBQMWCZKVMBLN-UHFFFAOYSA-N |
| LEDER | C1=CC=C(C=C1)S(=O)(=O)N |
| Molekylvikt (g/mol) | 157.19 |
| Synonym | benzenesulphonamide,benzosulfonamide,benzolsulfonamide,phenyl sulfonamide,benzene sulfonamide,phenylsulfonamide,m and b 7973,chembl27601,benzolsulfonamid,benzensulfonamide |
p-Toluenesulfonyl isocyanate, 96%
CAS: 4083-64-1 Molekylformel: C8H7NO3S Molekylvikt (g/mol): 197.21 MDL-nummer: MFCD00002030 InChI-nyckel: VLJQDHDVZJXNQL-UHFFFAOYSA-N Synonym: tosyl isocyanate,p-toluenesulfonyl isocyanate,4-methylbenzenesulfonyl isocyanate,p-toluenesulphonyl isocyanate,benzenesulfonyl isocyanate, 4-methyl,tosylisocyanate,p-tolylsulfonyl isocyanate,unii-h9004fjx6v,p-toluenesulfonic acid, anhydride with isocyanic acid,p-toluene sulfonyl isocyanate PubChem CID: 77703 IUPAC-namn: 4-metyl-N-(oxometyliden)bensensulfonamid LEDER: CC1=CC=C(C=C1)S(=O)(=O)N=C=O
| Molekylformel | C8H7NO3S |
|---|---|
| PubChem CID | 77703 |
| MDL-nummer | MFCD00002030 |
| IUPAC-namn | 4-metyl-N-(oxometyliden)bensensulfonamid |
| CAS | 4083-64-1 |
| InChI-nyckel | VLJQDHDVZJXNQL-UHFFFAOYSA-N |
| LEDER | CC1=CC=C(C=C1)S(=O)(=O)N=C=O |
| Molekylvikt (g/mol) | 197.21 |
| Synonym | tosyl isocyanate,p-toluenesulfonyl isocyanate,4-methylbenzenesulfonyl isocyanate,p-toluenesulphonyl isocyanate,benzenesulfonyl isocyanate, 4-methyl,tosylisocyanate,p-tolylsulfonyl isocyanate,unii-h9004fjx6v,p-toluenesulfonic acid, anhydride with isocyanic acid,p-toluene sulfonyl isocyanate |
NXT629, MedChemExpress
MedChemExpress NXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively. NXT629 has potent anti-tumor activity and inhibits experimental metastasis of cancer cell in animal models.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C35H39N5O3S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 609.78 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 125 mg/mL (204.99 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 1454925-59-7 |
| LEDER | O=S(C1=CC=CC=C1)(NC2=CC=C(C3=CC=C(CCCC(N4CC)=NN(CC5=CC=C(C(C)(C)C)C=C5)C4=O)C=C3)N=C2)=O |
| Molekylvikt (g/mol) | 609.78 |
| Kemiskt namn eller material | NXT629 |
| Procent renhet | 99.2% |
| För användning med (applikation) | Cancer-programmed cell death |
BMS-303141, MedChemExpress
MedChemExpress BMS-303141 is a potent, cell-permeable ATP-citrate lyase (ACL) inhibitor with an IC50 of 0.13 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H15Cl2NO4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 424.3 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : 25 mg/mL (58.92 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Powder |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 943962-47-8 |
| LEDER | O=S(C1=CC(Cl)=CC(Cl)=C1O)(NC2=CC(C3=CC=CC=C3)=CC=C2OC)=O |
| Molekylvikt (g/mol) | 424.3 |
| Kemiskt namn eller material | BMS-303141 |
| Procent renhet | 98.47% |
| För användning med (applikation) | Metabolism-sugar/lipid metabolism |
Acetohexamide, MedChemExpress
MedChemExpress Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2; stimulate the pancreas to secrete insulin.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C15H20N2O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 324.4 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 25 mg/mL (77.07 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 968-81-0 |
| LEDER | O=S(C1=CC=C(C(C)=O)C=C1)(NC(NC2CCCCC2)=O)=O |
| Molekylvikt (g/mol) | 324.4 |
| Kemiskt namn eller material | Acetohexamide |
| Procent renhet | 99.39% |
| För användning med (applikation) | Cancer-programmed cell death |
Etebenecid, MedChemExpress
MedChemExpress Etebenecid is a uricosuric agents, lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys, also inhibits penicillin tubular secretion.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
PKR-IN-2, MedChemExpress
MedChemExpress PKR-IN-2 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160. PKR-IN-2 can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H28N4O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 468.57 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 50 mg/mL (106.71 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1628428-01-2 |
| LEDER | N1C2C(=C(S(NC3=CC=C(C(N4CCC(O)(CC(C)C)CC4)=O)C=C3)(=O)=O)C=CC=2)N=CC=1 |
| Molekylvikt (g/mol) | 468.57 |
| Kemiskt namn eller material | PKR-IN-2 |
| Procent renhet | 95.14% |
| För användning med (applikation) | Cancer-Kinase/protease |
Orexin 2 Receptor Agonist, MedChemExpress
MedChemExpress Orexin 2 Receptor Agonist is a potent (EC50 on OX2R is 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio is 70) agonist.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C32H34N4O5S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 586.7 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 32 mg/mL (54.54 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1796565-52-0 |
| LEDER | O=C(C1=CC=CC(C)=C1)NCCNC2=CC(NS(C3=C(OC)C=CC(C4=CC(C(N(C)C)=O)=CC=C4)=C3)(=O)=O)=CC=C2 |
| Molekylvikt (g/mol) | 586.7 |
| Kemiskt namn eller material | Orexin 2 Receptor Agonist |
| Procent renhet | 99.75% |
| För användning med (applikation) | Neuroscience-Neuromodulation |
SU11274, MedChemExpress
MedChemExpress SU11274 is a selective Met inhibitor with IC50 of 10 nM, but has no effects on PGDFRβ, EGFR or Tie2.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C28H30ClN5O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 568.09 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (176.03 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Orange |
| CAS | 658084-23-2 |
| LEDER | O=S(C1=CC2=C(C=C1)NC(/C2=C/C3=C(C(C(N4CCN(CC4)C)=O)=C(N3)C)C)=O)(N(C)C5=CC=CC(Cl)=C5)=O |
| Molekylvikt (g/mol) | 568.09 |
| Synonym | PKI-SU11274 |
| Kemiskt namn eller material | SU11274 |
| Procent renhet | 98.19% |
| För användning med (applikation) | Cancer-Kinase/protease |
LX2343, MedChemExpress
MedChemExpress LX2343 is a BACE1 enzyme inhibitor with an IC50 value of 11.43±0.36 μM. LX2343 acts as a non-ATP competitive PI3K inhibitor with an IC50 of 15.99±3.23 μM. LX2343 stimulates autophagy in its promotion of Aβ clearance.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C22H19ClN2O6S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 474.91 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (210.57 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 333745-53-2 |
| LEDER | O=C(NC1=CC=C(OCO2)C2=C1)CN(C3=CC(Cl)=CC=C3OC)S(=O)(C4=CC=CC=C4)=O |
| Molekylvikt (g/mol) | 474.91 |
| Kemiskt namn eller material | LX2343 |
| Procent renhet | 99.74% |
| För användning med (applikation) | Neuroscience-Neurodegeneration |
Veralipride, MedChemExpress
MedChemExpress Veralipride is a D2 receptor antagonist. It is an alternative antidopaminergic treatment for menopausal symptoms.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C17H25N3O5S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 383.46 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (260.78 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 66644-81-3 |
| LEDER | O=C(NCC1N(CC=C)CCC1)C2=CC(S(=O)(N)=O)=CC(OC)=C2OC |
| Molekylvikt (g/mol) | 383.46 |
| Synonym | (±)-Veralipride LIR166 |
| Kemiskt namn eller material | Veralipride |
| Procent renhet | 99.57% |
| För användning med (applikation) | Neuroscience-Neurodegeneration |
Hydroxyhexamide, MedChemExpress
MedChemExpress Hydroxyhexamide is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agents.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C15H22N2O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 326.41 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 300 mg/mL (919.09 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 3168-01-2 |
| LEDER | O=S(C1=CC=C(C(O)C)C=C1)(NC(NC2CCCCC2)=O)=O |
| Molekylvikt (g/mol) | 326.41 |
| Synonym | (±)-Hydroxyhexamid |
| Kemiskt namn eller material | Hydroxyhexamide |
| Procent renhet | 99.68% |
| För användning med (applikation) | COVID-19-immunoregulation |
Alofanib, MedChemExpress
MedChemExpress Alofanib (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). Anticancer and antiangiogenic activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H15N3O6S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 413.4 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 30.1 mg/mL (72.81 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| CAS | 1612888-66-0 |
| LEDER | O=C(O)C1=CC=CC(S(=O)(NC2=CC(C3=CC=CN=C3)=C(C)C=C2[N+]([O-])=O)=O)=C1 |
| Molekylvikt (g/mol) | 413.4 |
| Synonym | RPT835 |
| Kemiskt namn eller material | Alofanib |
| Procent renhet | 98.81% |
| För användning med (applikation) | Cancer-Kinase/protease |
HMN-176, MedChemExpress
MedChemExpress HMN-176 is a stilbene derivative which inhibits mitosis, interfering with polo-like kinase-1 (plk1), without significant effect on tubulin polymerization.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C20H18N2O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 382.43 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 30 mg/mL (78.45 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 173529-10-7 |
| LEDER | O=S(C1=CC=C(OC)C=C1)(NC2=CC=CC=C2/C=C/C3=CC=N(C=C3)=O)=O |
| Molekylvikt (g/mol) | 382.43 |
| Kemiskt namn eller material | HMN-176 |
| Procent renhet | 98.54% |
| För användning med (applikation) | Cancer-Kinase/protease |